作者：
Sullivan, Ryan J. [1]
;
Hollebecque, Antoine [2]
;
Flaherty, Keith T. [3]
;
Shapiro, Geoffrey I. [4]
;
Ahnert, Jordi Rodon [5]
;
Millward, Michael J. [6]
;
Zhang, Wei [7]
;
Gao, Ling [8]
;
Sykes, Amanda [9]
;
Willard, Melinda D. [10]
;
Yu, Danni [11]
;
Schade, Andrew E. [12]
;
Crowe, KrisAnne [13]
;
Flynn, Daniel L. ;
Kaufman, Michael D. ;
Henry, James R. ;
Peng, Sheng-Bin ;
Benhadji, Karim A. ;
Conti, Ilaria ;
Gordon, Michael S. ;
Tiu, Ramon V. ;
Hong, David S.
作者单位：
Dana Farber Canc Inst, Boston, MA 02115 USA
[1]
Vall dHebron Inst Oncol, Barcelona, Spain
[2]
Massachusetts Gen Hosp, Dev Therapeut, Canc Ctr, Boston, MA USA
[3]
Deciphera Pharmaceut Inc, Waltham, MA USA
[4]
Eli Lilly & Co, Branchburg, NJ USA
[5]
EMD Serono, Boston, MA USA
[6]
Univ Western Australia, Linear Clin Res, Perth, WA, Australia
[7]
Eli Lilly & Co, Erl Wood, England
[8]
Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[9]
Gustave Roussy Canc Inst, Drug Dev Dept DITEP, Villejuif, France
[10]
Honor Hlth Res Inst, Scottsdale, AZ USA
[11]
Eli Lilly & Co, Indianapolis, IN 46285 USA
[12]
Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[13]
发布时间
2020-10-22
换一批
